10-Q 1 sanw-20240331.htm 10-Q 10-Q
--06-30Q30001477246false2024http://fasb.org/us-gaap/2023#ValuationTechniqueOptionPricingModelMemberhttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OperatingLeaseRightOfUseAssethttp://fasb.org/us-gaap/2023#OperatingLeaseRightOfUseAssethttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationshttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationshttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligations04-30-202407-31-2024one year10001477246us-gaap:ComputerSoftwareIntangibleAssetMember2024-03-310001477246us-gaap:InterestExpenseMember2022-07-012023-03-310001477246sanw:ScenarioTwoMembersanw:CIBCBankUSAMember2023-03-220001477246us-gaap:PreferredStockMember2023-03-310001477246us-gaap:EmployeeStockOptionMember2023-07-012024-03-310001477246us-gaap:CustomerListsMember2023-07-012024-03-310001477246sanw:CIBCBankUSAMember2023-06-300001477246sanw:VisionBioenergyOilseedsLlcMember2024-01-012024-03-310001477246us-gaap:RetainedEarningsMember2023-12-310001477246sanw:SeedSalesMember2023-01-012023-03-310001477246country:AR2023-01-012023-03-310001477246us-gaap:ComprehensiveIncomeMember2022-12-310001477246country:CN2023-01-012023-03-310001477246us-gaap:RestrictedStockUnitsRSUMember2024-03-310001477246us-gaap:MeasurementInputControlPremiumMember2024-03-310001477246us-gaap:CreditConcentrationRiskMemberus-gaap:AccountsReceivableMember2022-07-012023-06-300001477246us-gaap:CustomerContractsMember2023-07-012024-03-310001477246sanw:MFPLoanAgreementMember2022-09-222022-09-220001477246sanw:MFPLoanAgreementMember2022-09-220001477246sanw:EmployeeStockOptionsMember2023-07-012024-03-310001477246sanw:HysterMembersanw:MachineryAndEquipmentLoansLongTermCurrentMember2023-06-300001477246country:MX2024-01-012024-03-310001477246sanw:ShellOilProductsUsMembersanw:ConterraMembersanw:VisionBioenergyOilseedsLlcMember2022-07-012023-03-310001477246sanw:ShellOilProductsUsMembersanw:ConterraMembersanw:VisionBioenergyOilseedsLlcMember2023-07-012024-03-310001477246country:AU2022-07-012023-03-310001477246us-gaap:TradeNamesMember2023-07-012024-03-310001477246sanw:AtMarketIssuanceSalesAgreementMembersanw:BRileySecuritiesIncorporatedMember2022-05-170001477246us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMembersanw:CustomerOneMember2024-01-012024-03-310001477246sanw:TrigallAustraliaPtyLtdMember2022-07-012023-03-310001477246srt:MaximumMembersanw:MFPLoanAgreementMember2023-03-220001477246srt:MaximumMember2023-07-012024-03-310001477246country:AR2024-01-012024-03-310001477246sanw:VisionBioenergyOilseedsLlcMember2023-01-012023-03-310001477246sanw:ReferenceRateFloorMembersanw:MFPLoanAgreementMember2022-09-220001477246us-gaap:FairValueInputsLevel2Member2023-06-300001477246sanw:CIBCBankUSAMembersanw:ScenarioOneMember2023-03-220001477246sanw:MFPLoanAgreementMembersrt:MinimumMember2024-03-310001477246sanw:DepreciationAndAmortizationMember2023-01-012023-03-310001477246us-gaap:CommonStockMember2022-06-300001477246sanw:FlexibleRateTermLoanMember2023-07-012024-03-310001477246us-gaap:LandAndLandImprovementsMember2023-06-300001477246us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001477246us-gaap:ComputerSoftwareIntangibleAssetMember2023-06-3000014772462022-12-310001477246us-gaap:InterestExpenseMember2023-01-012023-03-310001477246us-gaap:LeaseholdImprovementsMember2024-03-310001477246us-gaap:EmployeeStockOptionMember2022-07-012023-03-310001477246us-gaap:CustomerListsMember2024-03-310001477246us-gaap:CommonStockMember2023-12-310001477246sanw:VisionBioenergyOilseedsLlcMember2023-06-300001477246us-gaap:PreferredStockMember2023-07-012024-03-310001477246sanw:TwoThousandNineAndTwoThousandNineteenPlanMember2023-07-012024-03-310001477246sanw:SecuredRealEstateNoteAgamericaLongTermNonCurrentMember2024-03-310001477246country:SA2023-07-012024-03-310001477246us-gaap:FairValueInputsLevel3Member2024-03-310001477246us-gaap:PreferredStockMember2024-01-012024-03-310001477246us-gaap:MeasurementInputRiskFreeInterestRateMembersrt:MinimumMember2024-03-310001477246us-gaap:FairValueInputsLevel1Member2023-06-300001477246us-gaap:ComprehensiveIncomeMember2023-03-310001477246sanw:SeriesBConvertiblePreferredStockMember2024-03-310001477246sanw:VisionBioenergyOilseedsLlcMember2024-01-012024-03-310001477246us-gaap:AdditionalPaidInCapitalMember2022-12-310001477246us-gaap:ServiceMember2023-07-012024-03-310001477246sanw:MFPLoanAgreementMember2024-01-012024-03-310001477246sanw:NationalAustraliaBankLimitedMembersanw:OverdraftCreditMember2023-11-170001477246sanw:VisionBioenergyOilseedsLlcMember2023-03-310001477246sanw:MFPLoanAgreementMember2022-12-222022-12-220001477246sanw:MasterAssetFinanceFacilityMembersrt:MaximumMember2023-07-012024-03-310001477246us-gaap:TreasuryStockCommonMember2023-03-310001477246sanw:AdamaCollaborationAgreementMembersanw:SeedSalesMember2023-01-012023-03-310001477246country:ZA2022-07-012023-03-310001477246us-gaap:LineOfCreditMemberus-gaap:SubsequentEventMembersanw:CIBCBankUSAMember2024-05-130001477246us-gaap:MachineryAndEquipmentMember2023-06-300001477246country:AR2022-07-012023-03-310001477246sanw:ShellOilProductsUsMember2023-07-012024-03-310001477246sanw:OverdraftFacilityMembersanw:NationalAustraliaBankLtdFacilityMember2024-03-310001477246us-gaap:CostOfSalesMember2024-01-012024-03-310001477246sanw:NationalAustraliaBankLimitedMembersanw:OverdraftCreditMember2023-11-172023-11-170001477246sanw:FordCreditMembersanw:VehicleLoansMember2024-03-310001477246sanw:DepreciationAndAmortizationMember2024-01-012024-03-310001477246us-gaap:AdditionalPaidInCapitalMember2023-07-012024-03-310001477246country:CN2023-07-012024-03-310001477246sanw:VisionBioenergyOilseedsLlcMember2022-07-012023-03-310001477246us-gaap:IntellectualPropertyMember2023-06-3000014772462022-07-012023-06-300001477246country:SD2024-01-012024-03-310001477246us-gaap:ResearchAndDevelopmentExpenseMember2023-07-012024-03-310001477246us-gaap:NonUsMember2024-03-310001477246us-gaap:PreferredStockMember2024-03-310001477246us-gaap:PreferredStockMember2023-12-310001477246us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembersanw:SignificantCustomerMember2022-07-012023-03-310001477246us-gaap:BuildingAndBuildingImprovementsMember2024-03-310001477246country:MX2023-07-012024-03-310001477246us-gaap:MeasurementInputPriceVolatilityMembersrt:MinimumMember2024-03-310001477246country:LY2024-01-012024-03-310001477246us-gaap:AdditionalPaidInCapitalMember2022-06-300001477246us-gaap:ComprehensiveIncomeMember2023-06-300001477246us-gaap:NoncontrollingInterestMember2023-12-310001477246sanw:VisionBioenergyOilseedsLlcMember2023-06-300001477246us-gaap:PreferredStockMember2023-01-012023-03-310001477246us-gaap:FairValueInputsLevel1Member2024-03-310001477246sanw:CIBCBankUSAMember2024-03-310001477246us-gaap:ComputerSoftwareIntangibleAssetMember2023-07-012024-03-310001477246sanw:CIBCBankUSAAndNationalAustraliaBankMember2023-06-300001477246sanw:TrigallAustraliaPtyLtdMembersanw:TrigallGeneticSAMember2023-07-012024-03-310001477246us-gaap:CustomerRelationshipsMember2023-07-012024-03-310001477246sanw:BorrowingBaseLineMembersanw:NationalAustraliaBankLtdFacilityMember2024-03-310001477246us-gaap:OtherNonoperatingIncomeExpenseMember2023-01-012023-03-310001477246country:LY2023-07-012024-03-310001477246us-gaap:CommonStockMember2022-12-310001477246us-gaap:AdditionalPaidInCapitalMember2023-12-310001477246sanw:VisionBioenergyOilseedsLlcMember2024-03-310001477246us-gaap:CommonStockMember2022-07-012023-03-310001477246us-gaap:PrimeRateMemberus-gaap:LineOfCreditMembersanw:CIBCBankUSAMember2023-03-222023-03-220001477246sanw:MFPLoanAgreementMember2022-10-280001477246us-gaap:ComprehensiveIncomeMember2023-12-310001477246sanw:TrigallAustraliaPtyLtdMember2023-01-012023-03-310001477246us-gaap:AdditionalPaidInCapitalMember2022-07-012023-03-310001477246us-gaap:IntellectualPropertyMember2024-03-310001477246sanw:AdamaCollaborationAgreementMembersanw:SeedSalesMember2024-01-012024-03-310001477246country:PK2023-07-012024-03-310001477246country:SA2023-01-012023-03-310001477246sanw:TrigallAustraliaPtyLtdMemberus-gaap:SubsequentEventMember2024-04-290001477246us-gaap:MeasurementInputPriceVolatilityMembersrt:MaximumMember2024-03-310001477246us-gaap:NonUsMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-07-012023-03-310001477246sanw:NationalAustraliaBankLtdFacilityMember2022-10-252022-10-250001477246sanw:ShellOilProductsUsMembersanw:VisionBioenergyOilseedsLlcMember2022-07-012023-03-310001477246us-gaap:VehiclesMember2023-06-300001477246us-gaap:AdditionalPaidInCapitalMember2023-06-300001477246us-gaap:CommonStockMember2023-03-310001477246us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-03-310001477246sanw:OtherCountriesMember2024-01-012024-03-310001477246sanw:TrigallAustraliaPtyLtdMember2024-03-310001477246us-gaap:CommonStockMember2024-01-012024-03-310001477246us-gaap:BuildingAndBuildingImprovementsMember2023-06-300001477246us-gaap:NoncontrollingInterestMember2024-03-310001477246sanw:AtMarketIssuanceSalesAgreementMembersanw:BRileySecuritiesIncorporatedMember2020-09-230001477246sanw:ShellOilProductsUsMembersanw:VisionBioenergyOilseedsLlcMember2023-07-012024-03-310001477246sanw:SeedSalesMember2024-01-012024-03-310001477246us-gaap:ForeignExchangeForwardMember2022-07-012023-03-310001477246sanw:MFPLoanAgreementMember2023-03-222023-03-220001477246sanw:VisionBioenergyOilseedsLlcMember2023-07-012024-03-310001477246sanw:SeriesBConvertiblePreferredStockMember2023-07-012024-03-310001477246sanw:TrigallAustraliaPtyLtdMember2023-06-300001477246us-gaap:RetainedEarningsMember2022-07-012023-03-310001477246sanw:TrigallAustraliaPtyLtdMemberus-gaap:SubsequentEventMember2024-04-292024-04-290001477246us-gaap:PreferredStockMember2022-07-012023-03-310001477246us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembersanw:MFPLoanAgreementMember2022-09-222022-09-220001477246us-gaap:TreasuryStockCommonMember2023-12-310001477246sanw:ShellOilProductsUsMembersrt:MinimumMember2023-02-062023-02-060001477246sanw:NationalAustraliaBankLimitedMembersanw:MachineryAndEquipmentLoansLongTermCurrentMember2023-06-300001477246sanw:TrigallAustraliaPtyLtdMember2023-07-012024-03-310001477246us-gaap:RestrictedStockUnitsRSUMember2022-07-012023-03-310001477246sanw:DepreciationAndAmortizationMember2023-07-012024-03-310001477246country:US2024-01-012024-03-310001477246us-gaap:NoncontrollingInterestMember2022-06-300001477246sanw:TwoThousandNineAndTwoThousandNineteenPlanMember2024-03-310001477246us-gaap:VehiclesMember2024-03-310001477246sanw:NationalAustraliaBankLimitedMembersanw:BorrowingBaseLineMember2022-10-2500014772462023-06-300001477246srt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMember2023-07-012024-03-310001477246country:LY2022-07-012023-03-310001477246sanw:EmployeeStockOptionsMembersrt:MinimumMember2023-07-012024-03-310001477246country:US2023-01-012023-03-310001477246us-gaap:InterestExpenseMember2024-01-012024-03-310001477246sanw:ShellOilProductsUsMembersanw:VisionBioenergyOilseedsLlcMember2024-03-310001477246us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-03-310001477246sanw:WarrantsIssuedWithSeriesBConvertiblePreferredStockMember2023-07-012024-03-310001477246us-gaap:ForeignExchangeForwardMember2024-03-310001477246sanw:HysterMembersanw:MachineryAndEquipmentLoansLongTermCurrentMember2024-03-3100014772462024-03-310001477246srt:MaximumMembersanw:MFPLoanAgreementMember2024-03-310001477246srt:MaximumMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2024-03-310001477246sanw:MFPLoanAgreementMember2022-10-282022-10-280001477246country:AU2023-01-012023-03-3100014772462023-03-310001477246sanw:MasterAssetFinanceFacilityMember2023-07-012024-03-310001477246us-gaap:CommonStockMember2023-07-012024-03-310001477246sanw:NationalAustraliaBankLimitedMember2024-03-310001477246us-gaap:NonUsMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310001477246sanw:MFPLoanAgreementMember2024-03-310001477246sanw:MasterAssetFinanceFacilityMember2024-03-310001477246us-gaap:CommonStockMember2023-06-300001477246us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001477246us-gaap:PrimeRateMemberus-gaap:LineOfCreditMembersanw:CIBCBankUSAMember2023-09-252023-09-250001477246us-gaap:ServiceMember2022-07-012023-03-310001477246sanw:SecuredRealEstateNoteMembersanw:AgamericaMember2023-06-200001477246sanw:SeriesBConvertiblePreferredStockMember2023-07-012024-03-310001477246sanw:SeriesBConvertiblePreferredStockMember2023-06-300001477246us-gaap:PreferredStockMember2022-12-310001477246us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001477246sanw:NationalAustraliaBankLimitedMember2023-06-300001477246sanw:OtherCountriesMember2023-07-012024-03-310001477246country:ZA2023-01-012023-03-3100014772462024-01-012024-03-310001477246us-gaap:FairValueInputsLevel3Member2023-06-300001477246us-gaap:OtherNonoperatingIncomeExpenseMember2022-07-012023-03-310001477246us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembersanw:SignificantCustomerMember2024-01-012024-03-310001477246us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-07-012024-03-310001477246country:SA2024-01-012024-03-310001477246srt:MaximumMembersanw:CIBCBankUSAMember2023-03-220001477246sanw:VisionBioenergyOilseedsLlcMember2024-03-310001477246sanw:TrigallAustraliaPtyLtdMember2022-12-310001477246us-gaap:AdditionalPaidInCapitalMember2023-03-310001477246us-gaap:OtherNonoperatingIncomeExpenseMember2024-01-012024-03-310001477246sanw:NationalAustraliaBankLimitedMemberus-gaap:LineOfCreditMember2024-03-310001477246sanw:ShellOilProductsUsMembersrt:MaximumMembersanw:VisionBioenergyOilseedsLlcMember2023-02-062023-02-060001477246country:SA2022-07-012023-03-310001477246us-gaap:ConstructionInProgressMember2023-06-3000014772462023-07-012024-03-310001477246us-gaap:RestrictedStockUnitsRSUMembersrt:MinimumMember2023-07-012024-03-310001477246sanw:TwoThousandNineteenPlanMember2024-03-310001477246us-gaap:CommonStockMember2023-01-012023-03-310001477246us-gaap:RestrictedStockUnitsRSUMember2022-07-012023-06-300001477246us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-03-310001477246country:AR2023-07-012024-03-310001477246us-gaap:RestrictedStockUnitsRSUMember2023-07-012024-03-310001477246us-gaap:InterestExpenseMember2023-07-012024-03-310001477246us-gaap:TreasuryStockCommonMember2024-03-310001477246us-gaap:ForeignExchangeForwardMember2024-01-012024-03-310001477246us-gaap:CustomerRelationshipsMember2023-06-300001477246sanw:TrigallAustraliaPtyLtdMember2023-12-310001477246us-gaap:StandbyLettersOfCreditMember2022-09-222022-09-220001477246sanw:ShellOilProductsUsMembersanw:VisionBioenergyOilseedsLlcMember2023-03-310001477246us-gaap:CustomerRelationshipsMember2024-03-310001477246us-gaap:LeaseholdImprovementsMember2023-06-300001477246us-gaap:NoncontrollingInterestMember2022-12-310001477246country:SD2022-07-012023-03-310001477246us-gaap:OtherNonoperatingIncomeExpenseMember2023-07-012024-03-310001477246sanw:SecuredRealEstateNoteMembersanw:AgamericaMember2023-06-202023-06-200001477246sanw:TrigallAustraliaPtyLtdMember2022-12-232022-12-230001477246us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembersanw:CustomerOneMember2023-07-012024-03-310001477246us-gaap:CreditConcentrationRiskMemberus-gaap:AccountsReceivableMembersrt:MinimumMembersanw:SignificantCustomerMember2022-07-012023-06-300001477246us-gaap:ForeignExchangeForwardMember2023-01-012023-03-310001477246sanw:NationalAustraliaBankLtdFacilityMember2023-11-172023-11-170001477246sanw:ShellOilProductsUsMember2023-02-060001477246sanw:DepreciationAndAmortizationMember2022-07-012023-03-310001477246sanw:SecuredRealEstateNoteMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMembersanw:AgamericaMember2023-06-202023-06-200001477246sanw:CIBCBankUSAMember2019-12-262019-12-260001477246country:PK2024-01-012024-03-310001477246sanw:NationalAustraliaBankLimitedMembersanw:BorrowingBaseLineMember2023-11-170001477246us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012024-03-310001477246us-gaap:IntellectualPropertyMember2023-07-012024-03-310001477246us-gaap:RetainedEarningsMember2024-01-012024-03-310001477246us-gaap:FairValueInputsLevel2Member2024-03-310001477246us-gaap:ServiceMember2023-01-012023-03-310001477246us-gaap:ComprehensiveIncomeMember2024-03-310001477246sanw:NationalAustraliaBankLimitedMembersanw:MachineryAndEquipmentLoansLongTermCurrentMember2024-03-310001477246sanw:FlexibleRateTermLoanMember2023-05-012023-05-310001477246country:MX2022-07-012023-03-310001477246us-gaap:RestrictedStockUnitsRSUMember2023-06-300001477246sanw:AdamaCollaborationAgreementMembersanw:SeedSalesMember2022-07-012023-03-310001477246us-gaap:PreferredStockMember2023-06-300001477246sanw:SeasonalCreditFacilityMembersanw:NationalAustraliaBankLtdFacilityMember2024-03-310001477246us-gaap:CustomerContractsMember2024-03-310001477246sanw:SecuredRealEstateNoteMembersanw:AgamericaMember2024-03-310001477246us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012023-03-310001477246us-gaap:RetainedEarningsMember2023-01-012023-03-310001477246us-gaap:AccountingStandardsUpdate201613Member2024-03-310001477246us-gaap:RestrictedStockUnitsRSUMember2023-07-012024-03-310001477246sanw:FlexibleRateTermLoanMember2024-03-310001477246sanw:NationalAustraliaBankLimitedMembersanw:OverdraftCreditMember2022-10-250001477246us-gaap:NoncontrollingInterestMember2023-06-300001477246sanw:TrigallAustraliaPtyLtdMember2023-03-310001477246us-gaap:NoncontrollingInterestMember2023-07-012024-03-310001477246us-gaap:CreditConcentrationRiskMemberus-gaap:AccountsReceivableMember2023-07-012024-03-310001477246sanw:MFPLoanAgreementMember2023-07-012024-03-310001477246us-gaap:RetainedEarningsMember2023-03-310001477246us-gaap:LandAndLandImprovementsMember2024-03-310001477246us-gaap:CostOfSalesMember2023-01-012023-03-3100014772462022-07-012023-03-310001477246us-gaap:NoncontrollingInterestMember2024-01-012024-03-310001477246us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012023-03-310001477246us-gaap:NoncontrollingInterestMember2022-07-012023-03-310001477246sanw:CIBCBankUSAMember2023-03-220001477246us-gaap:EmployeeStockOptionMember2023-07-012024-03-310001477246us-gaap:StandbyLettersOfCreditMember2023-03-222023-03-220001477246us-gaap:CostOfSalesMember2022-07-012023-03-310001477246sanw:ShellOilProductsUsMember2023-06-300001477246sanw:NationalAustraliaBankLimitedMembersanw:TermLoanLongTermCurrentMember2023-06-300001477246srt:MinimumMember2023-07-012024-03-310001477246sanw:CIBCBankUSAMember2023-07-012024-03-310001477246sanw:NationalAustraliaBankLimitedMembersanw:TermLoanLongTermCurrentMember2024-03-310001477246us-gaap:FederalFundsEffectiveSwapRateMemberus-gaap:LineOfCreditMembersanw:CIBCBankUSAMember2023-09-252023-09-2500014772462023-12-310001477246sanw:CIBCBankUSAAndNationalAustraliaBankMember2024-03-310001477246sanw:AtMarketIssuanceSalesAgreementMembersanw:BRileySecuritiesIncorporatedMember2023-07-012024-03-310001477246us-gaap:ConstructionInProgressMember2024-03-310001477246sanw:FordCreditMembersanw:VehicleLoansMember2023-06-300001477246country:SD2023-01-012023-03-310001477246us-gaap:MachineryAndEquipmentMember2024-03-310001477246us-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-03-310001477246sanw:TwoThousandNineAndTwoThousandNineteenPlanMember2024-01-012024-03-310001477246country:ZA2023-07-012024-03-310001477246sanw:SupplyAgreementMember2024-03-310001477246sanw:OtherCountriesMember2023-01-012023-03-310001477246us-gaap:AdditionalPaidInCapitalMember2024-03-310001477246us-gaap:ComprehensiveIncomeMember2022-06-300001477246sanw:VisionBioenergyOilseedsLlcMember2023-07-012024-03-310001477246sanw:MeasurementInputMarketabilityPremiumMember2024-03-310001477246country:CN2022-07-012023-03-310001477246sanw:ShellOilProductsUsMembersrt:MaximumMember2023-02-062023-02-060001477246us-gaap:LineOfCreditMembersanw:CIBCBankUSAMember2023-09-250001477246country:CN2024-01-012024-03-3100014772462023-01-012023-03-3100014772462024-05-080001477246country:US2022-07-012023-03-310001477246sanw:SeedSalesMember2023-07-012024-03-310001477246us-gaap:CustomerContractsMember2023-06-300001477246us-gaap:NonUsMember2023-07-012024-03-310001477246sanw:NationalAustraliaBankLimitedMembersanw:OverdraftCreditMember2024-03-192024-03-190001477246us-gaap:SalesRevenueNetMemberus-gaap:NonUsMemberus-gaap:GeographicConcentrationRiskMember2024-01-012024-03-310001477246country:PK2022-07-012023-03-310001477246us-gaap:CostOfSalesMember2023-07-012024-03-310001477246us-gaap:NonUsMember2023-06-300001477246sanw:SupplyAgreementMember2023-07-012024-03-310001477246us-gaap:TreasuryStockCommonMember2022-12-310001477246country:LY2023-01-012023-03-310001477246us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembersanw:SignificantCustomerMember2023-01-012023-03-310001477246us-gaap:CustomerListsMember2023-06-300001477246us-gaap:ServiceMember2024-01-012024-03-310001477246sanw:SharesOfCommonStockRelatedToMfpLoanAgreementMember2023-07-012024-03-310001477246sanw:AdamaCollaborationAgreementMembersanw:SeedSalesMember2023-07-012024-03-310001477246sanw:NationalAustraliaBankLimitedMembersanw:BorrowingBaseLineMember2023-11-172023-11-170001477246us-gaap:TreasuryStockCommonMember2023-06-300001477246us-gaap:RetainedEarningsMember2022-12-310001477246us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMemberus-gaap:NonUsMember2023-07-012024-03-310001477246sanw:TrigallAustraliaPtyLtdMember2024-01-012024-03-310001477246sanw:NationalAustraliaBankLtdFacilityMember2024-03-310001477246us-gaap:RetainedEarningsMember2023-07-012024-03-310001477246sanw:SeedSalesMember2022-07-012023-03-310001477246sanw:EmployeeStockOptionsMembersrt:MaximumMember2023-07-012024-03-310001477246country:US2023-07-012024-03-310001477246sanw:OtherCountriesMember2022-07-012023-03-310001477246sanw:SecuredRealEstateNoteAgamericaLongTermNonCurrentMember2023-06-300001477246us-gaap:CommonStockMember2024-03-310001477246srt:MaximumMemberus-gaap:ForeignExchangeForwardMember2023-07-012024-03-310001477246country:ZA2024-01-012024-03-310001477246us-gaap:RetainedEarningsMember2022-06-300001477246country:PK2023-01-012023-03-310001477246us-gaap:RetainedEarningsMember2023-06-300001477246us-gaap:ComprehensiveIncomeMember2022-07-012023-03-310001477246country:MX2023-01-012023-03-310001477246country:AU2024-01-012024-03-310001477246us-gaap:PreferredStockMember2022-06-300001477246us-gaap:TreasuryStockCommonMember2022-06-300001477246us-gaap:ComprehensiveIncomeMember2023-07-012024-03-310001477246us-gaap:ComprehensiveIncomeMember2023-01-012023-03-310001477246us-gaap:TradeNamesMember2024-03-310001477246country:AU2023-07-012024-03-310001477246us-gaap:RetainedEarningsMember2024-03-310001477246country:SD2023-07-012024-03-310001477246us-gaap:LineOfCreditMembersanw:CIBCBankUSAMember2024-03-310001477246us-gaap:ForeignExchangeForwardMember2023-07-012024-03-310001477246sanw:CIBCBankUSAMember2019-12-260001477246us-gaap:NoncontrollingInterestMember2023-03-310001477246us-gaap:ComprehensiveIncomeMember2024-01-012024-03-310001477246us-gaap:TradeNamesMember2023-06-300001477246sanw:VisionBioenergyOilseedsLlcMember2023-12-310001477246srt:MinimumMemberus-gaap:ForeignExchangeForwardMember2023-07-012024-03-310001477246us-gaap:StandbyLettersOfCreditMember2023-03-2200014772462022-06-300001477246sanw:MasterAssetFinanceFacilityMembersrt:MinimumMember2023-07-012024-03-310001477246sanw:SupplyAgreementMember2023-06-30iso4217:AUDsanw:Customersanw:Acresxbrli:pureiso4217:USDxbrli:sharesxbrli:sharesiso4217:USD

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____________ to _____________

Commission File Number: 001-34719

S&W SEED COMPANY

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada

 

27-1275784

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

 

 

 

 

 

 

2101 Ken Pratt Blvd, Suite 201, Longmont, CO

 

80501

(Address of Principal Executive Offices)

 

(Zip Code)

(720) 506-9191

(Registrant's Telephone Number, Including Area Code)

Securities Registered Pursuant to Section 12(b) of the Act:

 

Title of Each Class

Trading Symbol(s)

Name of Each Exchange on Which Registered

Common Stock, par value $0.001 per share

SANW

The Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large, accelerated filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

Emerging growth company

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

The number of shares outstanding of common stock of the registrant as of May 8, 2024 was 43,343,896.

 

 


 

S&W SEED COMPANY

TABLE OF CONTENTS

 

PART I.

 

FINANCIAL INFORMATION

 

Page No.

Item 1.

 

Financial Statements (Unaudited):

 

4

 

 

Condensed Consolidated Balance Sheets at March 31, 2024 and June 30, 2023

 

4

 

 

Condensed Consolidated Statements of Operations for the Three Months and Nine Months Ended March 31, 2024 and 2023

 

5

 

 

Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three Months and Nine Months Ended March 31, 2024 and 2023

 

6

 

 

Condensed Consolidated Statements of Mezzanine Equity and Stockholders’ Equity for the Three Months and Nine Months Ended March 31, 2024 and 2023

 

7

 

 

Condensed Consolidated Statements of Cash Flows for the Nine Months Ended March 31, 2024 and 2023

 

8

 

 

Notes to Condensed Consolidated Financial Statements

 

9

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

25

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

 

36

Item 4.

 

Controls and Procedures

 

36

PART II.

 

OTHER INFORMATION

 

38

Item 1.

 

Legal Proceedings

 

38

Item 1A.

 

Risk Factors

 

38

Item 2.

 

Unregistered Sales of Equity Securities and Use of Proceeds

 

38

Item 3.

 

Defaults Upon Senior Securities

 

38

Item 4.

 

Mine Safety Disclosures

 

38

Item 5.

 

Other Information

 

38

Item 6.

 

Exhibits

 

39

 

 

 

1


 

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. All statements other than statements of historical fact could be deemed forward-looking statements, including, but not limited to: statements concerning our loan agreements, including our ability to comply with and/or secure refinancing for such loan agreements; the potential effects of global macroeconomic events and the COVID-19 pandemic on our business; the plans, strategies and objectives of management for our future operations, including our expectations for new product introductions during fiscal 2024; our implementation of our strategic review (which includes our plans to reduce annual operating expenses) our partnership with Shell and its role in enabling us to reduce our operating expenses and sharpen our focus on key growth priorities; our ability to raise capital in the future; expected development, performance or market acceptance relating to our products or services or our ability to expand our grower or customer bases or to diversify our product offerings; future economic conditions or performance; our ability to retain key employees; and our assumptions, expectations and beliefs underlying any of the foregoing. These forward-looking statements are often identified by the use of words such as, but not limited to, “anticipate,” “believe,” “can,” “continue,” “could,” “designed,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “project,” “seek,” “should,” “target,” “will,” “would,” and similar expressions or variations intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We have based these forward-looking statements on our current expectations about future events. Such forward-looking statements are subject to risks, uncertainties and other important factors, including certain assumptions, that, if they never materialize or prove incorrect, could cause our actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Risks, uncertainties and assumptions include the following:

whether we are successful in implementing our strategies focused on growth opportunities, changes in our cost structure and improved financial performance;
whether we are able to maintain compliance with our current loan agreements, including to provide access to sufficient liquidity to pay our growers and suppliers;
the COVID-19 pandemic and other geopolitical and macroeconomic events, such as global inflation, bank failures, supply chain disruptions, uncertain market conditions, the ongoing military conflict between Russia and Ukraine and related sanctions, the armed conflict in Sudan, the conflict in the Middle East, and the extent to which they continue to disrupt the local and global economies, as well as our business and the businesses of our customers, distributors and suppliers;
changes in demand for our seed products, including Double TeamTM, our non-GMO herbicide tolerant sorghum solution;
whether we are able to develop and successfully launch additional trait technology products;
whether we are successful in commercializing our current and future trait technology products, including Double Team;
our plans for expansion of our business (including by expanding crop offerings and market share of existing offerings through acquisitions, partnerships, joint ventures and other strategic transactions) and our ability to successfully integrate acquisitions into our operations;
whether we continue to invest in research and development and whether such investment results in trait improvement across our crop categories;
the continued ability of our distributors and suppliers to have access to sufficient liquidity to fund their operations;
market trends and other factors affecting our financial condition or results of operations from period to period;
the impact of crop disease, severe weather conditions, such as drought or flooding, or natural disasters, such as earthquakes, on crop quality and yields and on our ability to grow, procure or export our products;
the impact of pricing of other crops that may influence what crops our growers elect to plant;
whether we are successful in aligning expense levels to revenue changes;
whether we are successful in monetizing camelina;
the cost and other implications of pending or future legislation or court decisions and pending or future accounting pronouncements;
whether our partnership with Shell provides its anticipated benefits; and
other risks that are described herein and in the section titled “Risk Factors” contained in Part I, Item 1A. of our Annual Report on Form 10-K for the fiscal year ended June 30, 2023, or the Annual Report, and that are otherwise described or updated from time to time in our filings with the Securities Exchange Commission.

You are urged to carefully review the disclosures made concerning risks and uncertainties that may affect our business or operating results, which include, among others, those described above.

2


 

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Many factors discussed in this Quarterly Report on Form 10-Q, some of which are beyond our control, will be important in determining our future performance. Consequently, these statements are inherently uncertain and actual results may differ materially from those that might be anticipated from the forward-looking statements. In light of these and other uncertainties, you should not regard the inclusion of a forward-looking statement in this Quarterly Report on Form 10-Q as a representation by us that our plans and objectives will be achieved, and you should not place undue reliance on such forward-looking statements. All forward-looking statements included herein are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Furthermore, such forward-looking statements represent our views as of, and speak only as of, the date of this Quarterly Report on Form 10-Q, and such statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. We undertake no obligation to publicly update any forward-looking statements, or to update the reasons why actual results could differ materially from those anticipated in any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

When used in this Quarterly Report on Form 10-Q, the terms “we,” “us,” “our,” “the Company,” “S&W” and “S&W Seed” refer to S&W Seed Company and its subsidiaries or, as the context may require, S&W Seed Company only. Our fiscal year ends on June 30, and accordingly, the terms “fiscal 2024,” “fiscal 2023” and “fiscal 2022” in this Quarterly Report on Form 10-Q refer to the respective fiscal year ended June 30, 2024, 2023 and 2022, respectively, with corresponding meanings to any fiscal year reference beyond such dates. Trademarks, service marks and trade names of other companies appearing in this report are the property of their respective holders.

3


 

PART I

FINANCIAL INFORMATION

Item 1. Financial Statements

S&W SEED COMPANY

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

ASSETS

 

As of
March 31, 2024

 

 

As of
June 30, 2023

 

CURRENT ASSETS

 

Cash and cash equivalents

 

$

171,009

 

 

$

3,398,793

 

Accounts receivable, net

 

 

22,459,754

 

 

 

24,622,727

 

Notes receivable, net

 

 

 

 

 

6,846,897

 

Inventories, net

 

 

43,484,334

 

 

 

45,098,268

 

Prepaid expenses and other current assets

 

 

2,561,455

 

 

 

4,099,027

 

TOTAL CURRENT ASSETS

 

 

68,676,552

 

 

 

84,065,712

 

Property, plant and equipment, net

 

 

9,912,619

 

 

 

10,082,168

 

Intellectual property, net

 

 

20,611,847

 

 

 

21,650,534

 

Other intangibles, net

 

 

7,426,679

 

 

 

8,082,325

 

Right of use assets - operating leases

 

 

2,460,730

 

 

 

2,983,303

 

Equity method investments

 

 

21,072,140

 

 

 

23,059,705

 

Other assets

 

 

3,049,792

 

 

 

2,066,081

 

TOTAL ASSETS

 

$

133,210,359

 

 

$

151,989,828

 

 

 

 

 

 

 

 

LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

Accounts payable

 

$

13,241,747

 

 

$

13,312,180

 

Deferred revenue

 

 

2,493,506

 

 

 

464,707

 

Accrued expenses and other current liabilities

 

 

7,395,982

 

 

 

8,804,456

 

Current portion of working capital lines of credit, net

 

 

42,031,443

 

 

 

44,900,779

 

Current portion of long-term debt, net

 

 

4,523,229

 

 

 

3,808,761

 

TOTAL CURRENT LIABILITIES

 

 

69,685,907

 

 

 

71,290,883

 

Long-term debt, net, less current portion

 

 

4,863,782

 

 

 

4,499,334

 

Other non-current liabilities

 

 

1,811,121

 

 

 

2,102,030

 

TOTAL LIABILITIES

 

 

76,360,810

 

 

 

77,892,247

 

MEZZANINE EQUITY

 

 

 

 

 

 

Preferred stock, $0.001 par value; 3,323 shares authorized; 1,695 issued and outstanding at March 31, 2024 and June 30, 2023

 

 

5,641,983

 

 

 

5,274,148

 

TOTAL MEZZANINE EQUITY

 

 

5,641,983

 

 

 

5,274,148

 

STOCKHOLDERS' EQUITY

 

 

 

 

 

 

Common stock, $0.001 par value; 75,000,000 shares authorized; 43,339,975 issued and 43,314,975 outstanding at March 31, 2024; 43,004,011 issued and 42,979,011 outstanding at June 30, 2023

 

 

43,340

 

 

 

43,004

 

Treasury stock, at cost, 25,000 shares at March 31, 2024 and June 30, 2023

 

 

(134,196

)

 

 

(134,196

)

Additional paid-in capital

 

 

168,540,941

 

 

 

167,768,104

 

Accumulated deficit

 

 

(109,889,570

)

 

 

(91,932,808

)

Accumulated other comprehensive loss

 

 

(7,410,638

)

 

 

(6,987,791

)

Non-controlling interests

 

 

57,689

 

 

 

67,120

 

TOTAL STOCKHOLDERS' EQUITY

 

 

51,207,566

 

 

 

68,823,433

 

TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS' EQUITY

 

$

133,210,359

 

 

$

151,989,828

 

 

See notes to condensed consolidated financial statements.

4


 

S&W SEED COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

 

 

Three Months Ended
March 31,

 

 

Nine Months Ended
March 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Revenue

 

$

18,324,635

 

 

$

17,662,307

 

 

$

45,621,910

 

 

$

50,465,974

 

Cost of revenue (excluding depreciation and amortization)

 

 

13,295,335

 

 

 

13,231,836

 

 

 

32,292,173

 

 

 

38,781,701

 

Gross profit

 

 

5,029,300

 

 

 

4,430,471

 

 

 

13,329,737

 

 

 

11,684,273

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

5,636,288

 

 

 

5,990,651

 

 

 

17,315,790

 

 

 

17,289,120

 

Research and development expenses

 

 

936,368

 

 

 

1,208,038

 

 

 

3,017,527

 

 

 

4,226,891

 

Depreciation and amortization

 

 

1,076,231

 

 

 

1,107,206

 

 

 

3,221,272

 

 

 

3,697,544

 

Loss (gain) on disposal of property, plant and equipment

 

 

11,065

 

 

 

37,325

 

 

 

(90,625

)

 

 

32,914

 

Total operating expenses

 

 

7,659,952

 

 

 

8,343,220

 

 

 

23,463,964

 

 

 

25,246,469

 

Loss from operations

 

 

(2,630,652

)

 

 

(3,912,749

)

 

 

(10,134,227

)

 

 

(13,562,196

)

Other (income) expense

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency loss

 

 

547,081

 

 

 

331,889

 

 

 

1,163,567

 

 

 

699,428

 

Government grant income

 

 

 

 

 

(1,444,044

)

 

 

 

 

 

(1,444,044

)

Gain on sale of business interest

 

 

 

 

 

(38,323,506

)

 

 

 

 

 

(38,323,506

)

Gain on sale of equity investment

 

 

 

 

 

 

 

 

 

 

 

(32,030

)

Gain on disposal of intangible assets

 

 

 

 

 

 

 

 

 

 

 

(1,796,252

)

Interest expense - amortization of debt discount

 

 

466,030

 

 

 

697,840

 

 

 

1,367,620

 

 

 

1,559,595

 

Interest expense, net

 

 

1,396,564

 

 

 

1,163,533

 

 

 

4,140,323

 

 

 

3,042,539

 

Other (income) expenses

 

 

(50,476

)

 

 

1,641,406

 

 

 

(147,370

)

 

 

1,597,683

 

(Loss) income before income taxes

 

 

(4,989,851

)

 

 

32,020,133

 

 

 

(16,658,367

)

 

 

21,134,391

 

Benefit from income taxes

 

 

(98,816

)

 

 

(500,118

)

 

 

(854,594

)

 

 

(884,078

)

(Loss) income before equity in net earnings of affiliates

 

 

(4,891,035

)

 

 

32,520,251

 

 

 

(15,803,773

)

 

 

22,018,469

 

Equity in loss of equity method investees, net of tax

 

 

586,451

 

 

 

406,678

 

 

 

2,124,676

 

 

 

410,692

 

Net (loss) income

 

$

(5,477,486

)

 

$

32,113,573

 

 

$

(17,928,449

)

 

$

21,607,777

 

(Loss) income attributable to non-controlling interests

 

 

23,051

 

 

 

(5,792

)

 

 

(9,431

)

 

 

(16,642

)

Net (loss) income attributable to S&W Seed Company

 

$

(5,500,537

)

 

$

32,119,365

 

 

$

(17,919,018

)

 

$

21,624,419

 

 

 

 

 

 

 

 

 

 

 

 

 

Calculation of net (loss) income per share:

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income attributable to S&W Seed Company

 

$

(5,500,537

)

 

$

32,119,365

 

 

$

(17,919,018

)

 

$

21,624,419

 

Dividends accrued for participating securities and accretion

 

 

(123,359

)

 

 

(121,137

)

 

 

(367,835

)

 

 

(349,260

)

Net (loss) income attributable to common shareholders

 

$

(5,623,896

)

 

$

31,998,228

 

 

$

(18,286,853

)

 

$

21,275,159

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income attributable to S&W Seed Company per common share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

(0.13

)

 

$

0.75

 

 

$

(0.42

)

 

$

0.50

 

Diluted

 

$

(0.13

)

 

$

0.74

 

 

$

(0.42

)

 

$

0.50

 

Weighted average number of common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

43,314,975

 

 

 

42,790,693

 

 

 

43,137,903

 

 

 

42,681,201

 

Diluted

 

 

43,314,975

 

 

 

43,166,148

 

 

 

43,137,903

 

 

 

42,873,830

 

 

See notes to condensed consolidated financial statements.

5


 

S&W SEED COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(UNAUDITED)

 

 

 

Three Months Ended
March 31,

 

 

Nine Months Ended
 March 31,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Net (loss) income

 

$

(5,477,486

)

 

$

32,113,573

 

 

$

(17,928,449

)

 

$

21,607,777

 

Foreign currency translation adjustment, net of income taxes

 

 

(578,482

)

 

 

(172,782

)

 

 

(422,847

)

 

 

(347,557

)

Comprehensive (loss) income

 

 

(6,055,968

)

 

 

31,940,791

 

 

 

(18,351,296

)

 

 

21,260,220

 

Comprehensive (loss) income attributable to non-controlling interests

 

 

23,051

 

 

 

(5,792

)

 

 

(9,431

)

 

 

(16,642

)

Comprehensive (loss) income attributable to S&W Seed Company

 

$

(6,079,019

)

 

$

31,946,583

 

 

$

(18,341,865

)

 

$

21,276,862

 

 

See notes to condensed consolidated financial statements.

6


 

S&W SEED COMPANY

CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY

(UNAUDITED)

 

 

 

Mezzanine Equity

 

 

Shareholders' Equity

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Treasury Stock

 

 

Additional
Paid-In

 

 

Accumulated

 

 

Non-
controlling

 

 

Accumulated
Other
Comprehensive

 

 

Total
Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Interests

 

 

Loss

 

 

Equity

 

Balance, December 31, 2022

 

 

1,695

 

 

$

5,032,942

 

 

 

42,788,423

 

 

$

42,788

 

 

 

(25,000

)

 

$

(134,196

)

 

$

165,444,354

 

 

$

(116,596,626

)

 

$

30,988

 

 

$

(6,735,375

)

 

$

42,051,933

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

619,892

 

 

 

 

 

 

 

 

 

 

 

 

619,892

 

Issuance of common stock for cash upon exercise of stock options

 

 

 

 

 

 

 

 

1,050

 

 

 

1

 

 

 

 

 

 

 

 

 

996

 

 

 

 

 

 

 

 

 

 

 

 

997

 

Subordinated loan & security agreement warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,092,000

 

 

 

 

 

 

 

 

 

 

 

 

1,092,000

 

Series B detachable warrant

 

 

 

 

 

25,838

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(25,838

)

 

 

 

 

 

 

 

 

(25,838

)

Accrued dividends on Series B convertible preferred stock

 

 

 

 

 

95,299

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(95,299

)

 

 

 

 

 

 

 

 

(95,299

)

Net issuance to settle RSUs

 

 

 

 

 

 

 

 

22,142

 

 

 

23

 

 

 

 

 

 

 

 

 

(12,737

)

 

 

 

 

 

 

 

 

 

 

 

(12,714

)

Proceeds from sale of common stock, net of expenses

 

 

 

 

 

 

 

 

102,455

 

 

 

102

 

 

 

 

 

 

 

 

 

152,648

 

 

 

 

 

 

 

 

 

 

 

 

152,750

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(172,782

)

 

 

(172,782

)

Net income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

32,119,365

 

 

 

(5,792

)

 

 

 

 

 

32,113,573

 

Balance, March 31, 2023

 

 

1,695

 

 

$

5,154,079

 

 

 

42,914,070

 

 

$

42,914

 

 

 

(25,000

)

 

$

(134,196

)

 

$

167,297,153

 

 

$

(84,598,398

)

 

$

25,196

 

 

$

(6,908,157

)

 

$

75,724,512

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, December 31, 2023

 

 

1,695

 

 

$

5,518,624

 

 

 

43,317,044

 

 

$

43,317

 

 

 

(25,000

)

 

$

(134,196

)

 

$

168,270,300

 

 

$

(104,595,765

)

 

$

34,638

 

 

$

(6,832,156

)

 

$

56,786,138

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

284,083

 

 

 

 

 

 

 

 

 

 

 

 

284,083

 

Series B detachable warrant

 

 

 

 

 

25,837

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(25,837

)

 

 

 

 

 

 

 

 

(25,837

)

Accrued dividends on Series B convertible preferred stock

 

 

 

 

 

97,522

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(97,522

)

 

 

 

 

 

 

 

 

(97,522

)

Net issuance to settle RSUs

 

 

 

 

 

 

 

 

22,931

 

 

 

23

 

 

 

 

 

 

 

 

 

(2,644

)

 

 

 

 

 

 

 

 

 

 

 

(2,621

)

Liquidation of subsidiary

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(10,798

)

 

 

330,091

 

 

 

 

 

 

 

 

 

319,293

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(578,482

)

 

 

(578,482

)

Net (loss) income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(5,500,537

)

 

 

23,051

 

 

 

 

 

 

(5,477,486

)

Balance, March 31, 2024

 

 

1,695

 

 

$

5,641,983

 

 

 

43,339,975

 

 

$

43,340

 

 

 

(25,000

)

 

$

(134,196

)

 

$

168,540,941

 

 

$

(109,889,570

)

 

$

57,689

 

 

$

(7,410,638

)

 

$

51,207,566

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mezzanine Equity

 

 

Shareholders' Equity

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Treasury Stock

 

 

Additional
Paid-In

 

 

Accumulated

 

 

Non-
controlling

 

 

Accumulated
Other
Comprehensive

 

 

Total
Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Interests

 

 

Loss

 

 

Equity

 

Balance, June 30, 2022

 

 

1,695

 

 

$

4,804,819

 

 

 

42,608,758

 

 

$

42,609

 

 

 

(25,000

)

 

$

(134,196

)

 

$

163,892,575

 

 

$

(105,873,557

)

 

$

41,838

 

 

$

(6,560,600

)

 

$

51,408,669

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,381,898

 

 

 

 

 

 

 

 

 

 

 

 

1,381,898

 

Issuance of common stock for cash upon exercise of stock options

 

 

 

 

 

 

 

 

1,050

 

 

 

1

 

 

 

 

 

 

 

 

 

996

 

 

 

 

 

 

 

 

 

 

 

 

997

 

Subordinated loan & security agreement warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,894,901

 

 

 

 

 

 

 

 

 

 

 

 

1,894,901

 

Series B detachable warrant

 

 

 

 

 

77,514

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(77,514

)

 

 

 

 

 

 

 

 

(77,514

)

Accrued dividends on Series B convertible preferred stock

 

 

 

 

 

271,746

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(271,746

)

 

 

 

 

 

 

 

 

(271,746

)

Net issuance to settle RSUs

 

 

 

 

 

 

 

 

201,807

 

 

 

202

 

 

 

 

 

 

 

 

 

(25,865

)

 

 

 

 

 

 

 

 

 

 

 

(25,663

)

Proceeds from sale of common stock, net of expenses

 

 

 

 

 

 

 

 

102,455

 

 

 

102

 

 

 

 

 

 

 

 

 

152,648

 

 

 

 

 

 

 

 

 

 

 

 

152,750

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(347,557

)